Safe switching from a pdFIX (Immunine®) to a rFIX (Bax326)-Reference-Cited by-同舟云学术

Safe switching from a pdFIX (Immunine®) to a rFIX (Bax326)

Published:2014-04-10 Issue:5 Volume:20 Page:674-681
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Solano Trujillo M. H.¹,Stasyshyn O.²,Rusen L.³,Serban M.⁴,Lamas J. L.⁵,Perina F. G.⁶,Urasinski T.⁷,Oh M.⁸,Knowlton W. B.⁹,Valenta-Singer B.⁹,Pavlova B. G.⁹,Abbuehl B.⁹

Affiliation:

1. Hospital de San Jose FUCS; Bogotá Colombia

2. Institute of Blood Pathology and Transfusion Medicine of Academy of Medical Sciences of Ukraine; Lviv Ukraine

3. S.C. Sanador SRL; Bucharest Romania

4. Louis Turcanu Emergency Clinical Children′s Hospital; Timisoara Romania

5. Dr. Sotero del Rio Hospital; Santiago Chile

6. Regional Clinical Hospital Ekaterinburg; Ekaterinburg Russia

7. Department of Paediatrics, Paediatric Hematology and Oncology; Pomeranian Medical University; Szczecin Poland

8. Baxter Healthcare Corporation; Westlake Village CA USA

9. Baxter Innovations GmbH; Vienna Austria

Funder

Baxter International

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hae.12444/fullpdf

Reference28 articles.

1. Biochemistry and physiology of blood coagulation;Mann;Thromb Haemost,1999

2. Molecular biology of blood coagulation;Oldenburg;Semin Thromb Hemost,2001

3. Virus safety of prothrombin complex concentrates and factor IX concentrates;Seitz;Thromb Res,1999

4. Efficacy and safety of monoclonal antibody purified factor IX concentrate in haemophilia B patients undergoing surgical procedures;Shapiro;Haemophilia,1997

5. Clinical evaluation of recombinant factor IX;White;Semin Hematol,1998

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clotting factor concentrates for preventing bleeding and bleeding-related complications in previously treated individuals with haemophilia A or B;Cochrane Database of Systematic Reviews;2021-08-18

2. A prospective surveillance study in haemophilia B patients following a population switch to recombinant factor IX (nonacog gamma);Haemophilia;2021-02-08

3. Systematic review and analysis of efficacy of recombinant factor IX products for prophylactic treatment of hemophilia B in comparison with rIX-FP;Journal of Medical Economics;2019-06-05

4. Using pharmacokinetics for tailoring prophylaxis in people with hemophilia switching between clotting factor products: A scoping review;Research and Practice in Thrombosis and Haemostasis;2019-05-20

5. Recombinant factorIX(BAX326) in previously treated paediatric patients with haemophilia B: a prospective clinical trial;Haemophilia;2014-12-11